Cargando…

Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder

Detalles Bibliográficos
Autores principales: Lee, Hye Won, Seo, Ho Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262491/
https://www.ncbi.nlm.nih.gov/pubmed/35796137
http://dx.doi.org/10.4111/icu.20220203
_version_ 1784742507499749376
author Lee, Hye Won
Seo, Ho Kyung
author_facet Lee, Hye Won
Seo, Ho Kyung
author_sort Lee, Hye Won
collection PubMed
description
format Online
Article
Text
id pubmed-9262491
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Korean Urological Association
record_format MEDLINE/PubMed
spelling pubmed-92624912022-07-13 Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder Lee, Hye Won Seo, Ho Kyung Investig Clin Urol Editorial The Korean Urological Association 2022-07 2022-06-22 /pmc/articles/PMC9262491/ /pubmed/35796137 http://dx.doi.org/10.4111/icu.20220203 Text en © The Korean Urological Association https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Lee, Hye Won
Seo, Ho Kyung
Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder
title Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder
title_full Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder
title_fullStr Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder
title_full_unstemmed Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder
title_short Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder
title_sort clinical implications and practical considerations for poly-adp-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262491/
https://www.ncbi.nlm.nih.gov/pubmed/35796137
http://dx.doi.org/10.4111/icu.20220203
work_keys_str_mv AT leehyewon clinicalimplicationsandpracticalconsiderationsforpolyadpribosepolymeraseinhibitorsasanewhorizonforthemanagementofurothelialcarcinomaofthebladder
AT seohokyung clinicalimplicationsandpracticalconsiderationsforpolyadpribosepolymeraseinhibitorsasanewhorizonforthemanagementofurothelialcarcinomaofthebladder